PepGen (PEPG) Capital Expenditures (2021 - 2025)
PepGen (PEPG) reported Capital Expenditures of -$1000.0 for Q4 2025, down 100.44% on a YoY basis from $228000.0 in Q4 2024, and down 101.03% sequentially from $97000.0 in Q3 2025.
PepGen (PEPG) Capital Expenditures (2021 - 2025) Analysis & Trends
PepGen (PEPG) has 5 years of Capital Expenditures data on file, last reported at -$1000.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures fell 100.44% year-over-year to -$1000.0; the trailing twelve-month figure through Mar 2026 stood at $139000.0 (down 75.57% YoY), and the FY2025 full-year result was $264000.0, down 46.88% from the prior year.
- Capital Expenditures slipped to -$1000.0 in Q4 2025, from $97000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.6 million in Q1 2022 to a low of -$1000.0 in Q4 2025.
- A 5-year average of $380750.0 and a median of $184500.0 in 2023 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures jumped 3960.0% in 2022 and sank 100.44% in 2025, its largest moves.
- Tracing PEPG's Capital Expenditures over 5 years: stood at $156000.0 in 2021, then surged by 606.41% to $1.1 million in 2022, then slumped by 83.3% to $184000.0 in 2023, then increased by 23.91% to $228000.0 in 2024, then tumbled by 100.44% to -$1000.0 in 2025.
- Business Quant data shows PEPG's Capital Expenditures at -$1000.0 in Q4 2025, $97000.0 in Q3 2025, and $43000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Mar 31, 2025 | 125,000.00 |
| Mar 31, 2025 | 125,000.00 |
| Dec 31, 2024 | 228,000.00 |
| Dec 31, 2024 | 228,000.00 |
| Sep 30, 2024 | 185,000.00 |
| Sep 30, 2024 | 185,000.00 |
| Jun 30, 2024 | 31,000.00 |
| Jun 30, 2024 | 31,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Dec 31, 2023 | 184,000.00 |
| Dec 31, 2023 | 184,000.00 |
| Sep 30, 2023 | 225,000.00 |
| Sep 30, 2023 | 225,000.00 |